Osteoarthritis Treatments
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
34
NCT05411575
Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 19, 2022
Completion: Oct 31, 2022
NCT05419856
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
Phase: Phase 1
Start: Aug 9, 2022
Completion: Oct 31, 2023
Loading map...